Claudia B. Manzo, PharmD

Office Director
FDA
Silver Spring, United States

Disclosure information not submitted.

Presentation(s):

• Impact of Risk Evaluation and Mitigation Strategies on Teratogenic Medications Among Publicly and Privately Insured Reproductive-Age Women

  Monday, August 26, 2024
  2:45 PM – 3:00 PM CEST